Dr. George Follows, a Consultant Haematologist at Cambridge University Hospitals and Professor of Haematology at Anglia Ruskin Medical School, discusses the critical evaluation of BTK inhibitors (BTKis) for the treatment of CLL and discussed its overall outcomes in CLL and relapsed CLL, as well as toxicity considerations.

 

 

Explore more videos

Configure Image Component

The CLL Management in Clinic

Dr. Hani Osman, UAE

Configure Image Component

Review on Fixed Duration Regimen in CLL Management

Dr. Mahmoud Marashi, UAE

Configure Image Component

Translating Data Into Practice

Dr. Ihab El-Hemaidi, KSA

Modal Window Component Section Begins
Modal Window Component Section Ends